Bristol Revenue Per Share from 2010 to 2024

BMY Stock  USD 55.78  0.50  0.89%   
Bristol Myers Revenue Per Share yearly trend continues to be fairly stable with very little volatility. Revenue Per Share is likely to outpace its year average in 2024. Revenue Per Share is the amount of revenue generated by Bristol Myers Squibb per share of stock, calculated by dividing total revenue by the average number of shares outstanding. View All Fundamentals
 
Revenue Per Share  
First Reported
2010-12-31
Previous Quarter
21.75253746
Current Value
22.84
Quarterly Volatility
5.6762161
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Bristol Myers financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Bristol Myers' main balance sheet or income statement drivers, such as Depreciation And Amortization of 10.3 B, Interest Expense of 1.2 B or Selling General Administrative of 3.6 B, as well as many indicators such as Price To Sales Ratio of 2.98, Dividend Yield of 0.0374 or PTB Ratio of 6.92. Bristol financial statements analysis is a perfect complement when working with Bristol Myers Valuation or Volatility modules.
  
Check out the analysis of Bristol Myers Correlation against competitors.

Latest Bristol Myers' Revenue Per Share Growth Pattern

Below is the plot of the Revenue Per Share of Bristol Myers Squibb over the last few years. It is the amount of revenue generated by a company per share of stock, calculated by dividing total revenue by the average number of shares outstanding. Bristol Myers' Revenue Per Share historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Bristol Myers' overall financial position and show how it may be relating to other accounts over time.
ViewLast Reported 23.4110 Years Trend
Slightly volatile
   Revenue Per Share   
       Timeline  

Bristol Revenue Per Share Regression Statistics

Arithmetic Mean14.36
Geometric Mean13.11
Coefficient Of Variation39.52
Mean Deviation4.68
Median12.63
Standard Deviation5.68
Sample Variance32.22
Range19.3016
R-Value0.93
Mean Square Error4.66
R-Squared0.87
Slope1.18
Total Sum of Squares451.07

Bristol Revenue Per Share History

2024 22.84
2023 21.75
2022 21.67
2021 20.88
2020 18.83
2019 15.33
2018 13.82

About Bristol Myers Financial Statements

Bristol Myers investors use historical fundamental indicators, such as Bristol Myers' Revenue Per Share, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Bristol Myers. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Revenue Per Share 21.75  22.84 

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Bristol Stock Analysis

When running Bristol Myers' price analysis, check to measure Bristol Myers' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bristol Myers is operating at the current time. Most of Bristol Myers' value examination focuses on studying past and present price action to predict the probability of Bristol Myers' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bristol Myers' price. Additionally, you may evaluate how the addition of Bristol Myers to your portfolios can decrease your overall portfolio volatility.